期刊文献+

腺病毒转染法构建表达乙型肝炎病毒核心蛋白小鼠肝癌细胞系及其在乙肝疫苗评价中的应用 被引量:8

Construction of HBV core antigen-expressing murine hepatoma cell line by adenovirus transfection method and its application in the evaluation of HBV vaccine
原文传递
导出
摘要 目的构建一种可高效表达乙型肝炎病毒(Hepatitis B virus,HBV)核心蛋白(HBc)C57BL/6小鼠来源肝癌细胞系,并以其作为靶细胞评价乙肝基因疫苗在C57BL/6小鼠体内所引起的HBe特异性细胞毒性T细胞(CTL)的活性。方法以HBV全基因组为模板,采用PCR方法扩增HBe基因,插入AdEasy腺病毒穿梭载体,构建携带HBe蛋白的腺病毒穿梭载体AD—HBe,电转携带有腺病毒骨架质粒(Ad—Easy)的EcoliBJ5183感受态细胞,获得重组腺病毒质粒AD-CMV.HBc,经Pme,线性化处理后转染HEK293细胞进行包装得到相关的重组腺病毒,再感染C57BL/6小鼠来源肝癌细胞系Hepal-6。结果成功构建表达HBc蛋白的重组腺病毒,在体外对Hepal一6细胞的感染率几乎为100%,并且HBc蛋白得到高效表达。以此为靶细胞用于pVAX1-HBe基因疫苗免疫C57BL/6小鼠产生的CTL活性的体外检测。结论我们成功构建HBe蛋白表达的靶细胞系,对研究乙肝病毒核心抗原(HBcAg)所引起的细胞免疫反应及乙肝发病机理等方面有重要意义。 Objective HBV core antigen-expressing cell line was constructed as target cells to study HBc-specific cytotoxic T cell(CTL) activity in HBV gene vaccine in C57BL/6 mice. Methods HBV core gene obtained by PCR was cloned into AdEasy adenovirus shuttle vector to construct the plasmid AD-HBc, then the shuttle vector was imported into the E. coli BJ5183 competent cells which carrying adenovirus back- bone plasmid to get the recombinant vector AD-CMV-HBc. The recombinant vector was transfected with the 293 cells by liposome-mediated method to produce the recombinant adenoviruses. Then the recombinant ade- noviruses were used to infect Hepal-6 cells. Results The recombinant adenovirus expressing HBc was suc- cessfully constructed. The Hepal-6 cells can be almost 100% infected in vitro. HBc protein was expressed in these cells by western bolt analysis. It worked very well when used as target cells in CTL response after C57BL/6 mice immunized with pVAX1-HBc. Conclusions We successfully constructed HBc expressing target cell lines. It may play an important role in detecting HBcAg CTL response and the pathogenesis of hepatitis B virus.
出处 《国际病毒学杂志》 2013年第1期1-5,共5页 International Journal of Virology
关键词 乙肝核心蛋白 重组腺病毒 小鼠肝癌细胞系 HBc protein Recombinant adenovirus Hepal-6 cells
  • 相关文献

参考文献16

  • 1罗红兵,郑群.慢性乙型肝炎基因治疗研究进展[J].国际病毒学杂志,2006,13(2):62-64. 被引量:1
  • 2Guidotti LG, Ishikawa T, Hobbs MV. Intracellular inactivation of the hepatitis B virus by cytotoxie T lymphocytes. Immunity, 1996, 4 (1) : 25-36.
  • 3Chisaii FV, Ferrari C. Hepatitis B virus immunopathology. springer semin immunopathol, 1995, 17 (2-3) : 261-281.
  • 4Nguyen MH, Keeffe EB. Chronic hepatitis B : early viral suppression and long-term outcomes of therapy with oral nucleos(t) ides. J viral Hepat, 2009, 16(3) : 149-155.
  • 5Thimme R, Wieland S, Steiger C, et al. CD8 ( + ) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Viral, 2003, 77 ( 1 ) : 68-76.
  • 6Chisari FV. Hepatitis B virus transgenic mice : insights into the virus and the disease. Hepatology, 1995, 22(4) : 1316-1325.
  • 7Guidotti LG, Ando K, Hobbs MV, et al. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mecha- nism in transgenic mice. Proc Natl Acad Sci USA, 1994, 91 (9) : 3764-3768.
  • 8Kimura K, Kakimi K, Wieland S, et al. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol, 2002, 76(21): 10702-10707.
  • 9Huang LR, Wu HL, Chen PJ, et al. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci USA, 2006, 103(47) : 17862-17867.
  • 10Paneda A, Vanrell L, Mauleon I, et al. Effect of adenoassociated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders. Hum Gene Ther, 2009, 20(8) : 908-917.

二级参考文献35

  • 1Shu Peiyuan,J Infect Dis,1994年,169卷,633页
  • 2Oscar B R,Hepatology,1997年,25卷,470页
  • 3Chen Leiping,J Experiment Med,1994年,179卷,523页
  • 4Mizuguchi H, Hayakawa T. Targeted adenovirus vectors . Hum Gene Ther, 2004,15(11):1034-1044.
  • 5http ://www. wiley, eom/legacy/wileychi/genmed/clinieal/.
  • 6McConnell M J, Imperiale MJ. Biology of adenovirus and its use as a vector for gene therapy. Hum Gene, Ther, 2004,15 (11):1022-1033.
  • 7.Wang X, Bergelson JM. Coxsackievirus and adenovirus receptor cytoplasmic and transmembrane domains are not essential for coxsackievirus and adenovirua infection. J Virol, 1999 Mar,73(3):2559-2562.
  • 8Oliver Meier Urs F. Greber. Adenovirus endocytosis. J Gene Med. ,2004(6) : 152-163.
  • 9Gao GP, Yang Y, Wilson JM. et al. Biology of adenovirus vectors with El and E4 deletions for liver-directed gene therapy. J Virol,1996, 70(12) :8934-8943.
  • 10Wang L, Hernandez Alcoceba R, Shankar V, Prolonged and inducible transgene expression in the liver using gutless adenovirus: a potential therapy for liver cancer. Gastroenterology, 2004, 126(1):278-89.

共引文献27

同被引文献77

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部